Anne Prener - Net Worth and Insider Trading

Anne Prener Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Anne Prener owns 3 companies in total, including Kaleido Biosciences Inc (KLDO) , Rubius Therapeutics Inc (RUBY) , and Galecto Inc (GLTO) .

Click here to see the complete history of Anne Prener’s form 4 insider trades.

Insider Ownership Summary of Anne Prener

Ticker	Comapny	Transaction Date	Type of Owner
KLDO	Kaleido Biosciences Inc	2020-04-01	director
RUBY	Rubius Therapeutics Inc	2019-12-17	director
GLTO	Galecto Inc	2021-01-08	director

Anne Prener Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Anne Prener Ownership Network

Ownership Network List of Anne Prener

No Data

Ownership Network Relation of Anne Prener

Anne Prener Owned Company Details

What does Kaleido Biosciences Inc do?

Who are the key executives at Kaleido Biosciences Inc?

Anne Prener is the director of Kaleido Biosciences Inc. Other key executives at Kaleido Biosciences Inc include Chief Medical Officer Alison S Long , Chief Scientific Officer Van Hylckama Vlieg Johan , and director & Chief Executive Officer Daniel L Menichella .

Kaleido Biosciences Inc (KLDO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kaleido Biosciences Inc (KLDO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kaleido Biosciences Inc (KLDO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kaleido Biosciences Inc (KLDO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Kaleido Biosciences Inc Insider Transactions

No Available Data

What does Rubius Therapeutics Inc do?

Who are the key executives at Rubius Therapeutics Inc?

Anne Prener is the director of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .

Rubius Therapeutics Inc (RUBY) Insider Trades Summary

Over the past 18 months, Anne Prener made no insider transaction in Rubius Therapeutics Inc (RUBY). Other recent insider transactions involving Rubius Therapeutics Inc (RUBY) include a net sale of 15,688 shares made by Pablo J Cagnoni , a net sale of 14,263 shares made by Dannielle Appelhans , and a net sale of 2,593 shares made by Laurence A. Turka .

In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc (RUBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,544 shares of Rubius Therapeutics Inc (RUBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,544 shares.

Rubius Therapeutics Inc (RUBY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rubius Therapeutics Inc Insider Transactions

No Available Data

What does Galecto Inc do?

Who are the key executives at Galecto Inc?

Anne Prener is the director of Galecto Inc. Other key executives at Galecto Inc include director & 10 percent owner Orbimed Advisors Llc , director & Chief Executive Officer Hans T. Schambye , and Chief Medical Officer Bertil Lindmark .

Galecto Inc (GLTO) Insider Trades Summary

Over the past 18 months, Anne Prener made no insider transaction in Galecto Inc (GLTO). Other recent insider transactions involving Galecto Inc (GLTO) include a net sale of 1,504,628 shares made by Orbimed Advisors Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Galecto Inc (GLTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,504,628 shares of Galecto Inc (GLTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,504,628 shares.

Galecto Inc (GLTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Galecto Inc Insider Transactions

No Available Data

Anne Prener Mailing Address

Above is the net worth, insider trading, and ownership report for Anne Prener. You might contact Anne Prener via mailing address: C/o Rubius Therapeutics, 399 Binney Street Suite 300, Cambridge Ma 02139.

Discussions on Anne Prener

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.